UniProt ID | PLRG1_HUMAN | |
---|---|---|
UniProt AC | O43660 | |
Protein Name | Pleiotropic regulator 1 | |
Gene Name | PLRG1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 514 | |
Subcellular Localization | Nucleus . Nucleus speckle . | |
Protein Description | Involved in pre-mRNA splicing as component of the spliceosome. [PubMed: 28502770] | |
Protein Sequence | MVEEVQKHSVHTLVFRSLKRTHDMFVADNGKPVPLDEESHKRKMAIKLRNEYGPVLHMPTSKENLKEKGPQNATDSYVHKQYPANQGQEVEYFVAGTHPYPPGPGVALTADTKIQRMPSESAAQSLAVALPLQTKADANRTAPSGSEYRHPGASDRPQPTAMNSIVMETGNTKNSALMAKKAPTMPKPQWHPPWKLYRVISGHLGWVRCIAVEPGNQWFVTGSADRTIKIWDLASGKLKLSLTGHISTVRGVIVSTRSPYLFSCGEDKQVKCWDLEYNKVIRHYHGHLSAVYGLDLHPTIDVLVTCSRDSTARIWDVRTKASVHTLSGHTNAVATVRCQAAEPQIITGSHDTTIRLWDLVAGKTRVTLTNHKKSVRAVVLHPRHYTFASGSPDNIKQWKFPDGSFIQNLSGHNAIINTLTVNSDGVLVSGADNGTMHLWDWRTGYNFQRVHAAVQPGSLDSESGIFACAFDQSESRLLTAEADKTIKVYREDDTATEETHPVSWKPEIIKRKRF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MVEEVQKH -------CCHHHHHH | 8.48 | 19413330 | |
7 | Acetylation | -MVEEVQKHSVHTLV -CCHHHHHHCHHHHH | 42.92 | 23749302 | |
12 | Phosphorylation | VQKHSVHTLVFRSLK HHHHCHHHHHHHHCC | 23.59 | 23312004 | |
31 | Acetylation | MFVADNGKPVPLDEE EEECCCCCCCCCCHH | 49.44 | 26051181 | |
31 | Ubiquitination | MFVADNGKPVPLDEE EEECCCCCCCCCCHH | 49.44 | 24816145 | |
31 (in isoform 1) | Ubiquitination | - | 49.44 | 21890473 | |
31 (in isoform 2) | Ubiquitination | - | 49.44 | 21890473 | |
41 | Acetylation | PLDEESHKRKMAIKL CCCHHHHHHHHHHHH | 64.09 | 26051181 | |
47 | Ubiquitination | HKRKMAIKLRNEYGP HHHHHHHHHHHCCCC | 31.68 | - | |
52 | Phosphorylation | AIKLRNEYGPVLHMP HHHHHHCCCCCCCCC | 30.22 | 21945579 | |
60 | Phosphorylation | GPVLHMPTSKENLKE CCCCCCCCCHHHHHH | 44.87 | 28555341 | |
62 | Acetylation | VLHMPTSKENLKEKG CCCCCCCHHHHHHHC | 53.77 | 26051181 | |
62 | Ubiquitination | VLHMPTSKENLKEKG CCCCCCCHHHHHHHC | 53.77 | 21906983 | |
62 (in isoform 1) | Ubiquitination | - | 53.77 | 21890473 | |
62 (in isoform 2) | Ubiquitination | - | 53.77 | 21890473 | |
68 | Ubiquitination | SKENLKEKGPQNATD CHHHHHHHCCCCCCC | 74.44 | 21906983 | |
68 (in isoform 1) | Ubiquitination | - | 74.44 | 21890473 | |
68 (in isoform 2) | Ubiquitination | - | 74.44 | 21890473 | |
76 | Phosphorylation | GPQNATDSYVHKQYP CCCCCCCCCCCCCCC | 25.38 | 28555341 | |
77 | Nitration | PQNATDSYVHKQYPA CCCCCCCCCCCCCCC | 14.91 | - | |
80 | Ubiquitination | ATDSYVHKQYPANQG CCCCCCCCCCCCCCC | 41.29 | 21906983 | |
80 (in isoform 1) | Ubiquitination | - | 41.29 | 21890473 | |
92 | Phosphorylation | NQGQEVEYFVAGTHP CCCCEEEEEEEECCC | 14.45 | 28796482 | |
97 | O-linked_Glycosylation | VEYFVAGTHPYPPGP EEEEEEECCCCCCCC | 15.22 | 55830677 | |
97 | Phosphorylation | VEYFVAGTHPYPPGP EEEEEEECCCCCCCC | 15.22 | 28796482 | |
113 | Ubiquitination | VALTADTKIQRMPSE EEEECCCCCEECCCH | 37.07 | 21906983 | |
113 (in isoform 1) | Ubiquitination | - | 37.07 | 21890473 | |
117 | Sulfoxidation | ADTKIQRMPSESAAQ CCCCCEECCCHHHHH | 2.16 | 21406390 | |
119 | Phosphorylation | TKIQRMPSESAAQSL CCCEECCCHHHHHHH | 34.54 | 25159151 | |
121 | Phosphorylation | IQRMPSESAAQSLAV CEECCCHHHHHHHHH | 32.99 | 25159151 | |
125 | Phosphorylation | PSESAAQSLAVALPL CCHHHHHHHHHHHCC | 17.36 | 20068231 | |
126 | Ubiquitination | SESAAQSLAVALPLQ CHHHHHHHHHHHCCC | 2.71 | 21963094 | |
126 (in isoform 2) | Ubiquitination | - | 2.71 | 21890473 | |
134 | Phosphorylation | AVALPLQTKADANRT HHHHCCCCCCCCCCC | 35.56 | 23186163 | |
135 | Acetylation | VALPLQTKADANRTA HHHCCCCCCCCCCCC | 31.16 | 25953088 | |
135 | Ubiquitination | VALPLQTKADANRTA HHHCCCCCCCCCCCC | 31.16 | 21906983 | |
135 (in isoform 1) | Ubiquitination | - | 31.16 | 21890473 | |
141 | Phosphorylation | TKADANRTAPSGSEY CCCCCCCCCCCCCCC | 42.60 | 27080861 | |
144 | Phosphorylation | DANRTAPSGSEYRHP CCCCCCCCCCCCCCC | 53.11 | 27080861 | |
146 | O-linked_Glycosylation | NRTAPSGSEYRHPGA CCCCCCCCCCCCCCC | 35.47 | 30379171 | |
146 | Phosphorylation | NRTAPSGSEYRHPGA CCCCCCCCCCCCCCC | 35.47 | 27080861 | |
148 | Phosphorylation | TAPSGSEYRHPGASD CCCCCCCCCCCCCCC | 18.87 | 27080861 | |
154 | Phosphorylation | EYRHPGASDRPQPTA CCCCCCCCCCCCCCC | 39.82 | 27080861 | |
160 | Phosphorylation | ASDRPQPTAMNSIVM CCCCCCCCCCCCEEE | 33.04 | 27080861 | |
164 | Phosphorylation | PQPTAMNSIVMETGN CCCCCCCCEEEECCC | 11.95 | 27080861 | |
164 | Ubiquitination | PQPTAMNSIVMETGN CCCCCCCCEEEECCC | 11.95 | 29967540 | |
164 (in isoform 2) | Ubiquitination | - | 11.95 | 21890473 | |
169 | Phosphorylation | MNSIVMETGNTKNSA CCCEEEECCCCCCCC | 20.03 | 27794612 | |
171 | Ubiquitination | SIVMETGNTKNSALM CEEEECCCCCCCCHH | 56.13 | 29967540 | |
173 | Ubiquitination | VMETGNTKNSALMAK EEECCCCCCCCHHCC | 53.56 | 21906983 | |
173 (in isoform 1) | Ubiquitination | - | 53.56 | 21890473 | |
175 | Phosphorylation | ETGNTKNSALMAKKA ECCCCCCCCHHCCCC | 25.08 | - | |
180 | 2-Hydroxyisobutyrylation | KNSALMAKKAPTMPK CCCCHHCCCCCCCCC | 35.19 | - | |
180 | Acetylation | KNSALMAKKAPTMPK CCCCHHCCCCCCCCC | 35.19 | 25953088 | |
180 | Ubiquitination | KNSALMAKKAPTMPK CCCCHHCCCCCCCCC | 35.19 | 29967540 | |
184 | Phosphorylation | LMAKKAPTMPKPQWH HHCCCCCCCCCCCCC | 51.47 | - | |
201 | Phosphorylation | WKLYRVISGHLGWVR CHHHHHHCCCCCEEE | 19.80 | 23186163 | |
220 (in isoform 2) | Ubiquitination | - | 5.59 | 21890473 | |
228 | Ubiquitination | TGSADRTIKIWDLAS ECCCCCEEEEEEECC | 2.95 | 21890473 | |
228 (in isoform 2) | Ubiquitination | - | 2.95 | 21890473 | |
229 | Ubiquitination | GSADRTIKIWDLASG CCCCCEEEEEEECCC | 36.81 | 21906983 | |
229 (in isoform 1) | Ubiquitination | - | 36.81 | 21890473 | |
237 | Ubiquitination | IWDLASGKLKLSLTG EEEECCCCEEEEEEC | 39.70 | 21906983 | |
237 (in isoform 1) | Ubiquitination | - | 39.70 | 21890473 | |
255 | Phosphorylation | TVRGVIVSTRSPYLF EEEEEEEECCCCEEE | 13.64 | 24732914 | |
256 | Phosphorylation | VRGVIVSTRSPYLFS EEEEEEECCCCEEEE | 25.03 | 24732914 | |
259 | Ubiquitination | VIVSTRSPYLFSCGE EEEECCCCEEEECCC | 26.93 | 27667366 | |
262 | Ubiquitination | STRSPYLFSCGEDKQ ECCCCEEEECCCCCE | 4.72 | 29967540 | |
268 | Acetylation | LFSCGEDKQVKCWDL EEECCCCCEEEEEEC | 53.33 | 25953088 | |
268 | Ubiquitination | LFSCGEDKQVKCWDL EEECCCCCEEEEEEC | 53.33 | 27667366 | |
271 | Acetylation | CGEDKQVKCWDLEYN CCCCCEEEEEECCCH | 27.41 | 26051181 | |
271 | Ubiquitination | CGEDKQVKCWDLEYN CCCCCEEEEEECCCH | 27.41 | 29967540 | |
277 | Phosphorylation | VKCWDLEYNKVIRHY EEEEECCCHHHHHHH | 27.81 | 28152594 | |
279 | Acetylation | CWDLEYNKVIRHYHG EEECCCHHHHHHHCC | 37.83 | 26051181 | |
279 | Ubiquitination | CWDLEYNKVIRHYHG EEECCCHHHHHHHCC | 37.83 | - | |
311 | Ubiquitination | VTCSRDSTARIWDVR EECCCCCCCEEEEEE | 25.01 | 23503661 | |
311 (in isoform 2) | Ubiquitination | - | 25.01 | 21890473 | |
320 | Ubiquitination | RIWDVRTKASVHTLS EEEEEECCEEEEECC | 28.27 | 21906983 | |
320 (in isoform 1) | Ubiquitination | - | 28.27 | 21890473 | |
354 | Ubiquitination | TGSHDTTIRLWDLVA ECCCCCEEEHHHHHC | 3.56 | 33845483 | |
354 (in isoform 2) | Ubiquitination | - | 3.56 | 21890473 | |
363 | Ubiquitination | LWDLVAGKTRVTLTN HHHHHCCCEEEEECC | 24.34 | 21906983 | |
363 (in isoform 1) | Ubiquitination | - | 24.34 | 21890473 | |
364 | Phosphorylation | WDLVAGKTRVTLTNH HHHHCCCEEEEECCC | 29.47 | 22210691 | |
372 | Ubiquitination | RVTLTNHKKSVRAVV EEEECCCCCEEEEEE | 49.14 | 29967540 | |
385 | Phosphorylation | VVLHPRHYTFASGSP EEECCCCEECCCCCC | 12.58 | 23186163 | |
386 | Phosphorylation | VLHPRHYTFASGSPD EECCCCEECCCCCCC | 13.44 | 28152594 | |
387 | Ubiquitination | LHPRHYTFASGSPDN ECCCCEECCCCCCCC | 3.92 | 21963094 | |
387 (in isoform 2) | Ubiquitination | - | 3.92 | 21890473 | |
389 | Phosphorylation | PRHYTFASGSPDNIK CCCEECCCCCCCCCC | 35.30 | 30108239 | |
390 | Ubiquitination | RHYTFASGSPDNIKQ CCEECCCCCCCCCCC | 39.51 | 22817900 | |
391 | Phosphorylation | HYTFASGSPDNIKQW CEECCCCCCCCCCCC | 26.95 | 25022875 | |
396 | Ubiquitination | SGSPDNIKQWKFPDG CCCCCCCCCCCCCCC | 57.25 | 21963094 | |
396 (in isoform 1) | Ubiquitination | - | 57.25 | 21890473 | |
399 | Ubiquitination | PDNIKQWKFPDGSFI CCCCCCCCCCCCCCE | 44.52 | 22817900 | |
445 | Phosphorylation | LWDWRTGYNFQRVHA EEECCCCCCCEEEEE | 16.52 | 28152594 | |
458 | Phosphorylation | HAAVQPGSLDSESGI EEEECCCCCCCCCCE | 35.37 | 26714015 | |
461 | Phosphorylation | VQPGSLDSESGIFAC ECCCCCCCCCCEEEE | 38.67 | 26714015 | |
463 | Phosphorylation | PGSLDSESGIFACAF CCCCCCCCCEEEEEE | 40.93 | 26714015 | |
468 | Glutathionylation | SESGIFACAFDQSES CCCCEEEEEECCCCC | 2.43 | 22555962 | |
478 | Ubiquitination | DQSESRLLTAEADKT CCCCCCEEEEECCCE | 4.08 | 29967540 | |
484 | Acetylation | LLTAEADKTIKVYRE EEEEECCCEEEEEEC | 60.23 | 23236377 | |
484 | Ubiquitination | LLTAEADKTIKVYRE EEEEECCCEEEEEEC | 60.23 | - | |
487 | Ubiquitination | AEADKTIKVYREDDT EECCCEEEEEECCCC | 38.14 | 29967540 | |
496 | Ubiquitination | YREDDTATEETHPVS EECCCCCCCCCCCCC | 36.12 | 29967540 | |
496 (in isoform 2) | Ubiquitination | - | 36.12 | 21890473 | |
501 | Ubiquitination | TATEETHPVSWKPEI CCCCCCCCCCCCHHH | 29.29 | 29967540 | |
505 | Acetylation | ETHPVSWKPEIIKRK CCCCCCCCHHHHCCC | 25.85 | 26051181 | |
505 | Ubiquitination | ETHPVSWKPEIIKRK CCCCCCCCHHHHCCC | 25.85 | 2190698 | |
505 (in isoform 1) | Ubiquitination | - | 25.85 | 21890473 | |
510 | Ubiquitination | SWKPEIIKRKRF--- CCCHHHHCCCCC--- | 58.49 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
119 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLRG1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLRG1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |